Phase 1 Metabolic Disorder Clinical Trials

5 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–5 of 5 trials

Recruiting

Phase 1Phase 2

Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases

HemoglobinopathiesMetabolic DisordersHematologic, Immune, or Bone Marrow Disorders+1 more

Washington University School of Medicine220 enrolled28 locationsNCT00920972

Recruiting

Phase 1

Clinical Investigation of Herbal Formulation and Its Efficacy in Polycystic Ovarian Syndrome

InfertilityPolycystic Ovarian Syndrome (PCOS)Herbal Medicine+1 more

Jinnah Postgraduate Medical Centre116 enrolled1 locationNCT07399535

Not Yet Recruiting

Phase 1

A Phase 1b Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Multiple Dose Safety and Tolerability Study of Daily Dosing of BL-001 for 12 Weeks in Adults with Obesity

Metabolic Disorders

Bloom Science Australia Pty Ltd48 enrolled2 locationsACTRN12626000061336

Recruiting

Phase 1Phase 2

Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

HemoglobinopathiesBone Marrow Failure SyndromesMetabolic Disorders+3 more

Washington University School of Medicine29 enrolled4 locationsNCT03128996

Completed

Phase 1

A Phase 1, Randomised, Double-blind, Placebo-controlled, First in Human Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of MVD1 in Normal Weight or Overweight Healthy Adult Volunteers and Multiple Doses of MVD1 in Overweight or Obese Healthy Adult Volunteers

ObesityMetabolic Disorders

Eolo Pharma Pty Ltd42 enrolled1 locationACTRN12622001519741